milnacipran has been researched along with Dizziness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horii, A; Imai, T; Inohara, H; Kitahara, T; Morita, Y; Takahashi, K; Uno, A | 1 |
| Clauw, DJ; Gendreau, RM; Mease, P; Palmer, RH; Wang, Y | 1 |
1 trial(s) available for milnacipran and Dizziness
| Article | Year |
|---|---|
Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
Topics: Adult; Aged; Capsules; Constipation; Cyclopropanes; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Pain; Pain Measurement; Patient Satisfaction; Placebos; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Vomiting | 2008 |
1 other study(ies) available for milnacipran and Dizziness
| Article | Year |
|---|---|
Psychiatric comorbidities and use of milnacipran in patients with chronic dizziness.
Topics: Anxiety Disorders; Chronic Disease; Comorbidity; Cyclopropanes; Depressive Disorder; Dizziness; Female; Fluvoxamine; Humans; Male; Mental Disorders; Middle Aged; Milnacipran; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 2016 |